• Product NameSucralfate
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivitySucralfate is a cytoprotective agent, an oral gastrointestinal medication primarily indicated for the treatment of active duodenal ulcers.
• Target NameFGFR; Others
• CAS No. 54182-58-0
• Calculated MW 2086.75
• Formulation C12H54Al16O75S8
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Metabolism system
  SMILES:O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(O)(=O)=O)O[C@H](OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H]1OS(O)(=O)=O
  Pathways:Angiogenesis; Others; Tyrosine Kinase/Adaptors
  Receptor:FGF2; Fibrinogen chain; Pepsin; PGF
  Boling pt:
  Melting pt:
  Solubility:Insoluble in cold Water.
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Terao N, et al. Arzneimittelforschung. 1980;30(1):76-8.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting